Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Guindon
John Guindon, Wawa CA
| Patent application number | Description | Published |
|---|---|---|
| 20080314372 | Cable Slinger and Method of Use Thereof - A cable slinging device comprising a sheath and a wrapper coupling mechanism wherein the device is adapted to enable a user to couple a wrapper to the coupling mechanism and subsequently release the wrapper during a throwing motion to move the wrapper from a first wrapper location to a second wrapper location. | 12-25-2008 |
Louise Guindon, Ville De Laval CA
| Patent application number | Description | Published |
|---|---|---|
| 20080257194 | Non-Toxic Metallic-Boron-Containing Ir Tracer Compositions and Ir Tracer Projectiles Containing the Same for Generating a Dim Visibility Ir Trace - A novel non-toxic IR tracer composition is provided herein which, when incorporated into an IR tracer projectile which is then fired, generates a dim visibility IR trace. Such IR tracer composition is a non-toxic, metallic-boron-containing, IR tracer composition comprising: from about 20 to about 30% by weight, or from about 45 to about 60% by weight, of potassium perchlorate; from about 5 to about 16% by weight of a metallic fuel which consists of metallic boron; from about 20 to about 25% by weight, or from about 40 to about 50% by weight, of a non-metallic fuel which consists of sodium salicylate; from about 5 to about 10% by weight of a retardant which consists either of iron carbonate or magnesium carbonate; and an effective amount of binder, wherein the total percentage of such ingredients add up to 100%. A novel IR tracer projectile containing such IR tracer composition for generating a dim visibility IR trace is also provided. | 10-23-2008 |
| 20080307995 | Non-Toxic Metallic-Metal Free Zinc Peroxide-Containing Ir Tracer Compositions and Ir Tracer Projectiles Containing Same for Generating a Dim Visibility Ir Trace - Novel non-toxic, heavy-metal free, zinc peroxide-containing, IR tracer compositions are provided herein, which, when incorporated into a medium caliber IR tracer projectile and fired, produce a dim visibility IR trace. Such IR tracer compositions comprise from about 65 to about 75% by weight, of zinc peroxide; from about 15 to about 25% by weight of a non-metallic fuel which consists of sodium salicylate; and an effective amount of a binder which is selected from the group consisting of calcium resinate and cellulose acetate butyrate. The total percentage of the ingredients adds up to 100%. Medium caliber, i.e., 0.50 caliber, IR tracer projectiles containing such IR tracer compositions are also provided. | 12-18-2008 |
| 20100300319 | LOW TOXICITY PRIMER COMPOSITIONS FOR REDUCED ENERGY AMMUNITION - A primer composition with reduced toxicity suited for reduced-energy ammunition comprises bismuth (III) oxide as the principal oxidizer and contains a portion of propellant composition mixed therein. This composition may also be used in a cartridge which is otherwise substantially free of any other propellant compound and preferably produces a residue which is substantially free of toxic substances. | 12-02-2010 |
Rick Guindon, Brookfield, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20110254237 | Wheelchair Stair Assist Apparatus - An apparatus is disclosed for use on standard or customized wheelchairs for moving the wheelchair and wheelchair occupant up or down a stairway or stairway-like structure (e.g., a curb) with greater confidence and stability to the occupant of the wheelchair and its handler(s). The apparatus includes a motorized assembly that interacts with stair steps when the apparatus and wheelchair are tilted backwardly. The motorized assembly allows the wheelchair to glide or move up or down the steps without experiencing the bumps commonly associated with rolling a wheelchair up or down a set of stairs. The apparatus includes a headrest to provide comfort to the occupant during operation and includes pivoting handlebars to allow the operator of the wheelchair to control the movement of the wheelchair. The apparatus is mountable to, and removable from (when not in use), the wheelchair. The apparatus can he considered as a retrofit. | 10-20-2011 |
Roger Guindon, Littleton, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20080314372 | Cable Slinger and Method of Use Thereof - A cable slinging device comprising a sheath and a wrapper coupling mechanism wherein the device is adapted to enable a user to couple a wrapper to the coupling mechanism and subsequently release the wrapper during a throwing motion to move the wrapper from a first wrapper location to a second wrapper location. | 12-25-2008 |
Yvan Guindon, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100093737 | Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use - The present invention comprises compounds useful as antiviral or antitumor agents. The compounds comprise nucleotide analogues that comprise tetrahydrofuranyl or tetrahydrothienyl moeities with quaternary centers at the 3′ position. The nucleotide analogues can be used to inhibit cancer or viruses. Accordingly, the compounds of the present invention are useful for treating, preventing, and/or inhibiting diseases or conditions associated with cancers and viruses. Thus, the present invention also comprising pharmaceutical formulations comprising the compounds and methods of using the compounds and formulations to inhibit viruses or tumors and treat, prevent, or inhibit the foregoing diseases. | 04-15-2010 |
| 20110092451 | NUCLEOTIDE ANALOGUES WITH QUATERNARY CARBON STEREOGENIC CENTERS AND METHODS OF USE - The present invention comprises compounds useful as antiviral or antitumor agents. The compounds comprise nucleotide analogues that comprise tetrahydrofuranyl or tetrahydrothienyl moeities with quaternary centers at the 3′ position. The nucleotide analogues can be used to inhibit cancer or viruses. Accordingly, the compounds of the present invention are useful for treating, preventing, and/or inhibiting diseases or conditions associated with cancers and viruses. Thus, the present invention also comprising pharmaceutical formulations comprising the compounds and methods of using the compounds and formulations to inhibit viruses or tumors and treat, prevent, or inhibit the foregoing diseases. | 04-21-2011 |